Nov 14,2019

DarioHealth Corp. CEO Erez Raphael Invited to Participate in BTIG Digital Health 2019

Dario's CEO, Erez Raphael, will be participating in a panel discussion at BTIG Digital Health 2019: Industry Innovators on What's Next, on Wednesday, November 20, 2019.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 14,2019

Cecelia Health Reaches One Million Patient Interactions Milestone and Raises Awareness for World Diabetes Day

Cecelia Health reaches its one-millionth live interaction with people suffering from chronic illness, doubling its coaching engagements from 2018 and proving that there is a light at the end of the tunnel. With its ability to scale the human touch backed by data-driven insights, Cecelia Health improves diabetes related health outcomes such as A1c reduction, medication adherence and associated quality measures.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Nov 14,2019

ASCENSIA DIABETES CARE CELEBRATES THE IMPORTANT ROLE FAMILIES PLAY IN SUPPORTING PEOPLE WITH DIABETES ON WORLD DIABETES DAY 2019

Today, Ascensia Diabetes Care, a leading global diabetes care company, has launched its campaign for World Diabetes Day 2019 in celebration of the crucial support that families provide to people with diabetes. By creating and sharing these videos, Ascensia is aiming to draw attention to the vital role that families play in diabetes care.

View Analyst & Ambassador Comments
Go to original news
Nov 15,2019

DarioHealth® Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes

The results suggest that personal health coaching, combined with regular health information captured on the Dario app, such as blood glucose levels, food and exercise, can significantly assist diabetes patients in managing and improving their chronic condition, potentially lowering their blood glucose levels to be in line with the American Diabetes Association (ADA) suggested A1c goals of 6.5% or less (equivalent to 140 mg/dL blood glucose average) for certain diabetic patients.

CLINICAL STUDY

#coaching

View Analyst & Ambassador Comments
Go to original news
Nov 18,2019

One Drop Announces Blood Glucose Predictive Capability for People Using Continuous Glucose Monitors

The capability is the latest milestone in using AI to improve self-care for people with diabetes, and builds on One Drop's AI-driven 8-hour blood glucose forecasts for users with type 2 diabetes, available in the One Drop mobile app as of this summer.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 19,2019

DIAMONTECH: ERSTMALIGE PRODUKTPRÄSENTATION DER 'D-BASE' AUF DER WELTGRÖSSTEN MEDIZINTECHNIK-MESSE COMPAMED/MEDICA 2019

The DiaMonTech product "D-Base", a device for the non-invasive measurement of blood sugar, will be presented at a trade fair for the first time at the COMPAMED/MEDICA 2019 medical technology trade fair by the partner company seleon GmbH.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 20,2019

Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Basal-IQ™ technology. Basal-IQ technology, a predictive low-glucose suspend (PLGS) algorithm, utilizes sensor values from an integrated Dexcom G6 continuous glucose monitor (CGM) to help reduce the frequency and duration of low-glucose events (hypoglycemia).

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 21,2019

Brighter invests in a digital healthcare provider and initiates partnership for digital health services

Brighter AB (publ) ("Brighter") has today entered into an agreement by which Brighter invests SEK 9 million in the healthcare provider Accumbo AB. The partnership starts with Brighters diabetes service Actiste® and Accumbo's care service for high blood pressure.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Nov 21,2019

Senseonics Publishes Positive Longitudinal Performance Over Multiple Sensor Insertions and Removal Cycles of the Eversense® CGM System

This real-world data of 945 adult users in the home-setting demonstrated that the performance of the sensor over four sensor cycles is stable and does not decrease over time. In addition, there was no degradation of patient glucose outcomes over the four sensor cycles.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 22,2019

BD to Present at Evercore ISI 2nd Annual HealthCONx Conference

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019, at 11:45 a.m. ET.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES